Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Consolidated Net Income (2024 - 2026)

Carlsmed filings provide 2 years of Consolidated Net Income readings, the most recent being -$8.6 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 84.78% to -$8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$28.3 million, a N/A change, with the full-year FY2025 number at -$29.3 million, down 21.54% from a year prior.
  • Consolidated Net Income hit -$8.6 million in Q4 2025 for Carlsmed, down from -$8.5 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of -$4.7 million in Q4 2024 to a low of -$8.6 million in Q4 2025.